Nuwacell Nets Hundreds of Mns of CNY in Series A
Nuwacell(Chinese:中盛溯源) completes hundreds of millions of CNY in a Series A financing round, which was jointly led by China Merchants Health (Chinese: 招商健康) and Legend Capital (Chinese: 君联资本) with participation from GF XINDE INVESTMENT (Chinese:广发信德). The financing will support the company in building a research and development platform and advancing its cellular drug pipeline.
Established in 2016, Nuwacell focuses on applying gene technology and stem cell technology to new drug research and development and biological drug production. The company focuses on the production and clinical transformation of iPSC-derived cell therapy products, and has systematically established a patent portfolio around the application of iPSC technology.
Briefing Feb 16, 2023 12:51 PM
· Healthcare
Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A
Briefing Feb 07, 2023 12:11 PM
· Healthcare
ForLong Biotech Nets Over CNY 100 Mn in Series A
In-depth
Briefing Feb 07, 2023 10:59 AM
· Healthcare
CytoCan Corp. Nets CNY 10 Mn in Seed Round
Briefing Jan 30, 2023 10:44 AM
· Healthcare
Levostar Completes Pre-A Financing Round to Further Invest in CGT
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 22, 2021 03:11 PM
Briefing Jan 18, 2023 10:59 AM
· Healthcare
BlissBio Nets Over CNY 100 Mn in Series B+
Briefing Sep 21, 2022 10:38 AM
· Healthcare
Weiyou Gene Nets Tens of Millions of CNY in Series Pre-A Round
Briefing Sep 16, 2022 11:10 PM
· Healthcare
NaviSeed Nets Tens of millions of CNY in Angel Round
Briefing Aug 31, 2022 08:30 PM
· Healthcare
Enitiatebio Nets One Hundred Million of CNY in Series A Round
Briefing Jun 28, 2022 09:56 AM
· Healthcare
And platinum medicine b7h4x4-1bb bispecific antibody were approved by FDA for new drug research
Briefing Jun 28, 2022 09:54 AM
· Healthcare
Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China
Briefing Jun 28, 2022 09:50 AM
· Healthcare
It is expected to achieve functional cure of chronic hepatitis B! GSK antisense therapy phase IIB positive clinical results
Briefing Jun 24, 2022 11:15 AM
· Healthcare
F-star to be acquired by China biopharmaceutical with USD 161million
Briefing Jun 24, 2022 11:07 AM
· Healthcare
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
Briefing Jun 24, 2022 10:46 AM
· Healthcare
East China medicine "liraglutide" goes to sea
See more
Read next
Insight
In-depth
Automotive · Analysis
How Malaysia Became Southeast Asia’s “Computing Power Hub”
Jan 07, 2026 12:24 PM
Insight
In-depth
Automotive · Analysis
Consumer-Grade 3D Printing Going Global Is Reaching a Watershed
Dec 29, 2025 05:40 PM
Insight
In-depth
Automotive · Analysis
Unpacking China | Key Chinese Firms to Watch This Week （14/12/2025-20/12/2025）
Dec 19, 2025 03:50 PM
Insight
In-depth